May Health Company
.jpg)
AblaCare has developped an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide women with more natural and less medicalized pregnancy. PCOS is the #1 cause of female infertility. Since 2017, they have been working on developing an innovative solution, aiming to restore ovulation in patients through a simple, one-time, durable, minimally invasive treatment. The Procedure can be performed in a clinic setting, without General Anesthesia, using the same minimally invasive access commonly used by fertility physicians for IVF.
Industry:
Reproductive Health & Contraception
Headquarters:
Paris, Ile-de-France, France
Founded Date:
01-01-2017
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2
Total Funding:
$11,204,444
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-07-09
Last Funding Type:
Series A
Register and Claim Ownership